B-SOFT Co Ltd
SZSE:300451

Watchlist Manager
B-SOFT Co Ltd Logo
B-SOFT Co Ltd
SZSE:300451
Watchlist
Price: 4.98 CNY 2.26% Market Closed
Market Cap: 7.7B CNY

B-SOFT Co Ltd
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

B-SOFT Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B-SOFT Co Ltd
SZSE:300451
Cash & Cash Equivalents
ÂĄ724.7m
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
12%
Y
Yidu Tech Inc
HKEX:2158
Cash & Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
-27%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Medlive Technology Co Ltd
HKEX:2192
Cash & Cash Equivalents
ÂĄ3.8B
CAGR 3-Years
0%
CAGR 5-Years
151%
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Cash & Cash Equivalents
ÂĄ289.6m
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Winning Health Technology Group Co Ltd
SZSE:300253
Cash & Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
28%
B
BrainAurora Medical Technology Ltd
HKEX:6681
Cash & Cash Equivalents
ÂĄ343.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

B-SOFT Co Ltd
Glance View

Market Cap
7.7B CNY
Industry
Health Care

B-SOFT Co Ltd finds its roots in the vibrant tech landscape of China, gradually carving a niche in the healthcare information technology industry. The company, founded in the late 1990s, is headquartered in Hangzhou, a city renowned for its robust tech ecosystem. B-SOFT initially emerged as a nimble provider of digital solutions aimed at elevating the healthcare sector's operational efficiency. Its energies are devoted to developing software that streamlines hospital resource management, electronic medical records, and telemedicine services. By integrating their solutions into the fabric of healthcare institutions, B-SOFT enables these entities to offer more efficient patient care, meeting the increasing demand for digital healthcare infrastructure. The company generates revenue primarily through the sales of its software products and services. It offers a suite of software solutions to hospitals and healthcare providers, adopting a business model that combines software licensing fees and maintenance contracts. In addition to this, B-SOFT capitalizes on professional services through consultations and custom software development, allowing healthcare organizations to tailor systems to their specific needs. Its strategic focus on the healthcare sector's digital transformation hasn't just set B-SOFT apart from many generic tech solution providers—it has anchored its growth in a rapidly evolving industry where the shift to digital is both a necessity and an opportunity. This focus on specialized solutions serves as B-SOFT’s cornerstone, anchoring its journey amidst the technological revolution sweeping through healthcare.

Intrinsic Value
4.55 CNY
Overvaluation 9%
Intrinsic Value
Price

See Also

What is B-SOFT Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
724.7m CNY

Based on the financial report for Sep 30, 2025, B-SOFT Co Ltd's Cash & Cash Equivalents amounts to 724.7m CNY.

What is B-SOFT Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%

Over the last year, the Cash & Cash Equivalents growth was 5%. The average annual Cash & Cash Equivalents growth rates for B-SOFT Co Ltd have been -17% over the past three years , -12% over the past five years , and 12% over the past ten years .

Back to Top